Compared to patients with Kawasaki syndrome, patients with SLE and COVID-19 tended to have an increased proportion of LCs (Fig. 3, B and C), with an enrichment in conventional CD4+ or CD8+ T cells and NK cells and, to a lesser extent, in γδ T cells. This evidence concerns the gene CD8A and systemic lupus erythematosus.